ABBV position history
The shares of AbbVie (ABBV) that MATRIX ASSET ADVISORS INC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 466,214 shares, $50M, 7.1% of portfolio
- 2021 Q4: 233,263 shares, $32M, 4.1% of portfolio, Reduce −50.0%
- 2022 Q1: 178,882 shares, $29M, 3.9% of portfolio, Reduce −23.3%
- 2022 Q2: 148,058 shares, $23M, 3.5% of portfolio, Reduce −17.2%
- 2022 Q3: 162,704 shares, $22M, 3.6% of portfolio, Add +9.9%
- 2022 Q4: 158,459 shares, $26M, 3.8% of portfolio, Reduce −2.6%
- 2023 Q1: 158,010 shares, $25M, 3.6% of portfolio, Reduce −0.3%
- 2023 Q2: 160,982 shares, $22M, 3.0% of portfolio, Add +1.9%
- 2023 Q3: 161,302 shares, $24M, 3.4% of portfolio, Add +0.2%
- 2023 Q4: 164,427 shares, $25M, 3.2% of portfolio, Add +1.9%
- 2024 Q1: 142,956 shares, $26M, 3.1% of portfolio, Reduce −13.1%
- 2024 Q2: 145,247 shares, $25M, 3.0% of portfolio, Add +1.6%
- 2024 Q3: 101,261 shares, $20M, 2.2% of portfolio, Reduce −30.3%
- 2024 Q4: 104,029 shares, $18M, 2.0% of portfolio, Add +2.7%
- 2025 Q1: 39,119 shares, $8.2M, 0.90% of portfolio, Reduce −62.4%
- 2025 Q2: 77,022 shares, $14M, 1.4% of portfolio, Add +96.9%
- 2025 Q3: 38,813 shares, $9M, 0.83% of portfolio, Reduce −49.6%
- 2025 Q4: 38,285 shares, $8.7M, 0.79% of portfolio, Reduce −1.4%
- 2026 Q1: 39,175 shares, $8.5M, 0.78% of portfolio, Add +2.3%
- 2026 Q2: 39,070 shares, $9.8M, 0.80% of portfolio, Reduce −0.3%
- 2026 Q3: 33,896 shares, $8.9M, 0.73% of portfolio, Reduce −13.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|